Yildiz Fidan, Kobak Şenol, Semİz Hüseyin, Orman Mehmet
Department of Chest Disease, Okan University Faculty of Medicine, İstanbul, Turkey.
Department of Internal Medicine, Division of Rheumatology, Istinye University Faculty of Medicine, İstanbul, Turkey.
Arch Rheumatol. 2020 Jan 8;35(2):259-263. doi: 10.46497/ArchRheumatol.2020.7649. eCollection 2020 Jun.
This study aims to determine the frequency and characteristics of autoimmune diseases associated with sarcoidosis patients.
The study included 131 sarcoidosis patients (36 males, 95 females; mean age 46.1 years; range, 20 to 82 years). Demographic, clinical, laboratory and radiological data of patients were evaluated retrospectively. The characteristics of autoimmune diseases associated with sarcoidosis (sarcoidosis-overlap group) patients and isolated sarcoidosis (isolated sarcoidosis group) were analyzed and compared.
Concomitant autoimmune diseases were detected in 15 (11.5%) (5 males, 10 females; mean age 50.8 years; range, 26 to 58 years) of the 131 patients with sarcoidosis and their mean disease duration was three months (range, 1 to 30 months). When compared with isolated sarcoidosis patients, more hand finger joint involvement, rheumatoid factor (RF) positivity, higher erythrocyte sedimentation rate (ESR) and less nonsteroidal anti-inflammatory drugs (NSAIDs) usage were found in the sarcoidosis-overlap group (p=0.035, p=0.049, p=0.015, p=0.018, respectively). There were no statistically significant differences between the two groups when evaluated for demographic, clinical parameters and disease-modifying antirheumatic drugs usage.
Concomitant autoimmune diseases in patients with sarcoidosis may be rarely seen. These patients are characterized with more hand finger joint involvement, RF positivity, higher ESR and less NSAIDs usage. Multicenter, prospective studies involving large numbers of patients are needed to understand whether the association of sarcoidosis-autoimmune diseases is based only on coincidence or on a common etiopathogenesis.
本研究旨在确定结节病患者相关自身免疫性疾病的发生率及特征。
本研究纳入了131例结节病患者(男性36例,女性95例;平均年龄46.1岁;范围20至82岁)。对患者的人口统计学、临床、实验室及放射学数据进行回顾性评估。分析并比较结节病相关自身免疫性疾病患者(结节病重叠组)和孤立性结节病患者(孤立性结节病组)的特征。
131例结节病患者中有15例(11.5%)(男性5例,女性10例;平均年龄50.8岁;范围26至58岁)检测到合并自身免疫性疾病,其平均病程为3个月(范围1至30个月)。与孤立性结节病患者相比,结节病重叠组手部手指关节受累更多、类风湿因子(RF)阳性、红细胞沉降率(ESR)更高且非甾体抗炎药(NSAIDs)使用更少(分别为p = 0.035、p = 0.049、p = 0.015、p = 0.018)。在评估人口统计学、临床参数及改善病情抗风湿药使用情况时,两组之间无统计学显著差异。
结节病患者合并自身免疫性疾病可能少见。这些患者的特征为手部手指关节受累更多、RF阳性、ESR更高且NSAIDs使用更少。需要开展涉及大量患者的多中心前瞻性研究,以了解结节病与自身免疫性疾病的关联是仅基于巧合还是基于共同的病因发病机制。